Focal therapy for localized prostate cancer - Current status

Area of Science:

• Oncology
• Urology
• Medical Physics

Background:

• Localized prostate cancer (PCa) traditionally treated with radical therapies.
• Radical treatments often result in significant side effects impacting urinary, sexual, and bowel functions.
• Growing interest in focal therapy (FT) as a less invasive alternative for PCa management.

Purpose of the Study:

• To review the current landscape of focal therapy (FT) for localized prostate cancer (PCa).
• To discuss various ablative modalities employed in FT for PCa.
• To assess the efficacy and safety profile of FT in managing PCa.

Main Methods:

• Literature review of studies on focal therapy for prostate cancer.
• Analysis of different energy-based ablative techniques used in FT.
• Evaluation of clinical outcomes, including cancer control and side effect profiles.

Main Results:

• Focal therapy targets cancerous lesions in the prostate, sparing healthy tissue.
• Minimizes common side effects like urinary incontinence and sexual dysfunction associated with radical treatments.
• Various ablative modalities are available for delivering energy to target tissues.

Conclusions:

• Focal therapy represents a promising organ-sparing approach for localized prostate cancer.
• FT offers a potential reduction in treatment-related morbidity compared to radical options.
• Further research and standardization of techniques are ongoing for FT in PCa.